Ischemic heart disease Board decisions

The Board denied service connection for ischemic heart disease as new and relevant evidence was not presented or secured.

The Board denied service connection for hearing loss and tinnitus, while remanding the claims for coronary artery disease (CAD), prostate cancer, obstructive sleep apnea, cataracts, and thyroid removal due to a duty to assist error.

The Board granted service connection for coronary artery disease, hypertension, and prostate cancer based on the Veteran's exposure to herbicide agents during his service near the Korean Demilitarized Zone.

The Board remands the claim for service connection for heart disorder, to include ischemic heart disease, for further development and examination.

The Board denied the increased rating claim for coronary artery disease and TDIU from July 30, 2019, to October 16, 2019.

The Board granted service connection for type II diabetes mellitus, coronary artery disease with angina, myocardial infarction, and peripheral neuropathy of the bilateral lower and upper extremities due to exposure to herbicide agents during service. The claims for deep vein thrombosis and cellulitis were remanded.

The Board remands the claims for service connection for a low back disorder, obstructive sleep apnea (OSA), and a heart disorder for additional development to obtain new VA medical opinions.

The Veteran withdrew his appeal for service connection for headaches, PTSD, a heart condition, and joint pains.

The Board granted service connection for sleep apnea and a total disability rating based on individual unemployability (TDIU) from April 4, 2024.

The Board remands the claims for service connection for hypertension, a heart disability, and an acquired psychiatric disorder to obtain additional medical opinions.

The Board denied service connection for malignant melanoma, bilateral hearing loss, and urinary tract condition. It granted an initial 10 percent evaluation for hypertension associated with herbicide exposure.

The application to readjudicate the claim for an earlier effective date prior to October 30, 2016, for service connection of CAD s/p 3 vessel CABG was denied due to a lack of new and relevant evidence.

The Board denied the veteran's claims for increased ratings for diabetes mellitus, PTSD, and CAD, but granted an earlier effective date for service connection of right upper extremity neuropathy.

The Board denied the Veteran's claim for an earlier effective date for service connection of coronary artery disease, as the grant was based on the PACT Act and no other theory of entitlement supported an earlier date.

The Board denied service connection for the cause of the Veteran's death, finding that his myocardial infarction and coronary artery disease were not related to his military service.

The Board granted service connection for sleep apnea and CAD as secondary to the Veteran's service-connected temporomandibular joint dysfunction.

The Board remands the claims for service connection for liver and heart conditions due to a need for VA examinations that address in-service toxic exposure risk activity (TERA) and direct service connection.

The Board denied the veteran's claims for increased ratings and effective dates, except for a 20 percent rating granted for left and right lower extremity diabetic peripheral neuropathy femoral nerve.

The Board granted service connection for coronary artery disease, diabetes mellitus, left and right leg peripheral neuropathy, and the Veteran's cause of death due to lung cancer with metastasis.

The Board remands the claims for service connection for various conditions, including diabetes mellitus, type II, and peripheral neuropathy in both lower extremities, among others.